SynthesisFrontiers in endocrinology2025
Global prevalence estimates of diffuse idiopathic skeletal hyperostosis: a systematic review and meta-analysis.
Synthesis in Frontiers in endocrinology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed.
- Association of diffuse idiopathic skeletal hyperostosis with postoperative outcomes following surgery for degenerative lumbar spine disease.European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society · 2026Article
- Severe Aerodigestive Compromise Caused by Cervical Diffuse Idiopathic Skeletal Hyperostosis: A Case Report.Journal of orthopaedic case reports · 2026Article
- Dysphagia Secondary to Cervical Hyperostosis in Diffuse Idiopathic Skeletal Hyperostosis: A Case Report.Cureus · 2026Article
- Article
- Descriptive Analysis and Postoperative Surgical Complications of Ankylosing Spondylitis and Diffuse Idiopathic Skeletal Hyperostosis Patients at a Midwest Tertiary Referral Center.The Iowa orthopaedic journal · 2026Article
- Genetics and pathophysiology of diffuse idiopathic skeletal hyperostosis.Frontiers in endocrinology · 2026Review
- When bone bridges become barriers-a case of DISH-related dysphagia.Oxford medical case reports · 2025Article
- Acute Laryngeal Dyspnoea Revealing Anterior Cervical Hyperostosis (Forestier's Disease).European journal of case reports in internal medicine · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Diffuse idiopathic skeletal hyperostosis (DISH) is a whole-body disease characterized by ossification or calcification of joints and ligaments, which is present on all continents and in all ethnic groups. However, there is a lack of comprehensive information on the global prevalence and incidence of DISH. Objective: To conduct a systematic review and meta-analysis to investigate the global prevalence of DISH. Methods: Three electronic medical databases (Cochrane Database of Systematic Reviews, MEDLINE, and Embase) were used to conduct a systematic review of population-based and clinical-based studies reporting the prevalence of DISH from the time of commencement to February 2023. "Prevalence or epidemiology" and "diffuse idiopathic skeletal hyperostosis or DISH" were the search terms used. There were no language restrictions. Extract data based on features such as continent, gender, age, and race. Quality was assessed using the Critical Appraisal Tool for Prevalence Data Reporting Studies from the Joanna Briggs Institute, which synthesizes the available evidence using a random effects model. Results: Among the 33 studies, the overall estimated prevalence of DISH in the general population (n=36925) was 11.92% (95% CI, 8.68%-15.59%), and the overall prevalence of DISH in clinical patients (n=22969) was about 14.30% (95%CI, 10.10%-19.09%). In 17 population-based studies, the prevalence of DISH was 10.07% (95% CI, 6.76%-13.95%) in Asia, 11.16% (95% CI, 6.19%-17.36%) in Europe, 13.46% in North America (95%CI, 12.20%-14.77%) and 30.07% (95%CI, 25.90%-34.49%) in Oceania. The overall prevalence of DISH by sex was 6.49% (95%CI, 3.65%-10.07%) in women and 17.87% (95%CI, 13.27%-22.98%) in men. The prevalence rate of Asians was 10.07% (95%CI, 6.76%-13.95%), that of white people was 11.90% (95%CI, 7.62%-16.98%), and that of black people was 8.77% (95%CI, 6.39%-11.67%). In 16 clinic-based studies, the prevalence of DISH was 16.32% (95%CI, 10.10%-23.67%) in Asia, 13.20% (95%CI, 9.89%-16.92%) in Europe, and 13.13%(95%CI, 3.79%-26.93%) in North America and 3.93% in Africa. According to gender classification, the overall prevalence of DISH was 10.16% (95%CI, 6.59%-14.38%) in women and 18.73% (95%CI, 12.84%-25.44%) in men. The prevalence rate of Asians was 16.45% (95%CI, 7.45%-28.05%), that of white people was 14.95% (95%CI, 10.28%-20.31%), and that of black people was 5.71% (95%CI, 2.57%-9.98%). Conclusions: This study identifies the global prevalence of DISH in terms of population distribution, space, and time. The overall prevalence of DISH was approximately 11.92% (95%CI, 8.68%-15.59%) in the general population and 14.30% (95% CI, 10.10%-19.09%) in clinical patients. The prevalence of DISH was higher in males, and those aged 50 and over.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.